{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:10:55Z","timestamp":1792174255417,"version":"4.4.0"},"reference-count":83,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.4693","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T15:02:19Z","timestamp":1590073339000},"page":"e204693","source":"Crossref","is-referenced-by-count":187,"title":["Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia"],"prefix":"10.1001","volume":"3","author":[{"given":"Katherine","family":"Beck","sequence":"first","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"Psychiatric Imaging Group, MRC (Medical Research Council) London Institute of Medical Sciences, Hammersmith Hospital, London, United Kingdom"},{"name":"South London and Maudsley NHS (National Health Service) Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Hindley","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Borgan","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Ginestet","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McCutcheon","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"Psychiatric Imaging Group, MRC (Medical Research Council) London Institute of Medical Sciences, Hammersmith Hospital, London, United Kingdom"},{"name":"South London and Maudsley NHS (National Health Service) Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Brugger","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"Division of Psychiatry, University College London, London, United Kingdom"},{"name":"Cardiff University Brain Research Imaging Centre, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Driesen","sequence":"additional","affiliation":[{"name":"Yale University Medical School, Veterans Affairs Connecticut Health Care System, West Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohini","family":"Ranganathan","sequence":"additional","affiliation":[{"name":"Yale University Medical School, Veterans Affairs Connecticut Health Care System, West Haven"},{"name":"Department of Psychiatry and National Center for Posttraumatic Stress Disorder (PTSD), Veterans Affairs Connecticut Healthcare System, West Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Cyril","family":"D\u2019Souza","sequence":"additional","affiliation":[{"name":"Yale University Medical School, Veterans Affairs Connecticut Health Care System, West Haven"},{"name":"Department of Psychiatry and National Center for Posttraumatic Stress Disorder (PTSD), Veterans Affairs Connecticut Healthcare System, West Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"University Department of Psychiatry, Warneford Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Krystal","sequence":"additional","affiliation":[{"name":"Yale University Medical School, Veterans Affairs Connecticut Health Care System, West Haven"},{"name":"Department of Veteran Affairs National Center for Posttraumatic Stress Disorder, Clinical Neurosciences Division, Veterans Affairs Connecticut Healthcare System, West Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver D.","family":"Howes","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"Psychiatric Imaging Group, MRC (Medical Research Council) London Institute of Medical Sciences, Hammersmith Hospital, London, United Kingdom"},{"name":"South London and Maudsley NHS (National Health Service) Foundation Trust, London, United Kingdom"},{"name":"Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"zoi200224r1","article-title":"Ketamine: a review.","author":"Stevenson","year":"2005","journal-title":"Updat Anaesth"},{"issue":"1-3","key":"zoi200224r2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pain.2009.08.015","article-title":"Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study.","volume":"147","author":"Schwartzman","year":"2009","journal-title":"Pain"},{"issue":"9","key":"zoi200224r3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/archpsyc.62.9.985","article-title":"Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.","volume":"62","author":"Krystal","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"zoi200224r4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0361-9230(01)00646-3","article-title":"A systems model of altered consciousness: integrating natural and drug-induced psychoses.","volume":"56","author":"Vollenweider","year":"2001","journal-title":"Brain Res Bull"},{"issue":"3","key":"zoi200224r5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses.","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"zoi200224r6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1017\/S0033291714001603","article-title":"A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.","volume":"45","author":"McGirr","year":"2015","journal-title":"Psychol Med"},{"issue":"2","key":"zoi200224r7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial.","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"15","key":"zoi200224r8","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-analysis of Observational Studies in Epidemiology (MOOSE) group.","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"10","key":"zoi200224r9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"zoi200224r10","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/npp.2012.8","article-title":"Dose-related modulation of event-related potentials to novel and target stimuli by intravenous ?9-THC in humans.","volume":"37","author":"D\u2019Souza","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"zoi200224r11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41398-018-0191-x","article-title":"Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.","volume":"8","author":"Morgan","year":"2018","journal-title":"Transl Psychiatry"},{"issue":"9896","key":"zoi200224r12","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"zoi200224r13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0920-9964(94)00088-P","article-title":"Variability in BPRS definitions of positive and negative symptoms.","volume":"17","author":"Nicholson","year":"1995","journal-title":"Schizophr Res"},{"issue":"7829","key":"zoi200224r16","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"zoi200224r18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package.","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"issue":"August","key":"zoi200224r19","first-page":"1","article-title":"The efficacy and heterogeneity of antipsychotic response in schizophrenia: a meta-analysis.","author":"McCutcheon","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"11","key":"zoi200224r20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/jamapsychiatry.2017.2663","article-title":"Heterogeneity and homogeneity of regional brain structure in schizophrenia: a meta-analysis.","volume":"74","author":"Brugger","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"20","key":"zoi200224r21","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1002\/sim.v31.20","article-title":"A multivariate meta-analysis approach for reducing the impact of outcome reporting bias in systematic reviews.","volume":"31","author":"Kirkham","year":"2012","journal-title":"Stat Med"},{"issue":"1","key":"zoi200224r22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2288-11-41","article-title":"Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics.","volume":"11","author":"Bowden","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"7414","key":"zoi200224r23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7109","key":"zoi200224r24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"zoi200224r25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","article-title":"Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.","volume":"17","author":"Malhotra","year":"1997","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"zoi200224r26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers.","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"zoi200224r27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0893-133X(98)00031-1","article-title":"The apolipoprotein E e 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia: a preliminary report.","volume":"19","author":"Malhotra","year":"1998","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"zoi200224r28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0269881115570082","article-title":"Optimizing the glutamatergic challenge model for psychosis, using S+-ketamine to induce psychomimetic symptoms in healthy volunteers.","volume":"29","author":"Kleinloog","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"4","key":"zoi200224r29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1503\/jpn.160187","article-title":"Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans.","volume":"42","author":"Thiebes","year":"2017","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"zoi200224r30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/mp.2016.122","article-title":"Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers.","volume":"22","author":"Kraguljac","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"2","key":"zoi200224r31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"zoi200224r32","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/sj.npp.1300994","article-title":"Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism.","volume":"31","author":"Krystal","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"zoi200224r33","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/brain\/awy175","article-title":"Acute ketamine dysregulates task-related gamma-band oscillations in thalamo-cortical circuits in schizophrenia.","volume":"141","author":"Grent-\u2019t-Jong","year":"2018","journal-title":"Brain"},{"issue":"6","key":"zoi200224r34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.biopsych.2017.12.019","article-title":"Dose-related target occupancy and effects on circuitry, behavior, and neuroplasticity of the glycine transporter-1 inhibitor pf-03463275 in healthy and schizophrenia subjects.","volume":"84","author":"D\u2019Souza","year":"2018","journal-title":"Biol Psychiatry"},{"issue":"3","key":"zoi200224r35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002130050503","article-title":"Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.","volume":"135","author":"Krystal","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"zoi200224r36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0893-133X(00)00240-2","article-title":"Clinical and sensorimotor gating effects of ketamine in normals.","volume":"25","author":"Duncan","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"zoi200224r37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-005-0177-2","article-title":"The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers.","volume":"183","author":"Parwani","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"zoi200224r38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.npp.1300642","article-title":"Selective cognitive impairments associated with NMDA receptor blockade in humans.","volume":"30","author":"Rowland","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"zoi200224r39","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/ajp.154.6.805","article-title":"Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.","volume":"154","author":"Breier","year":"1997","journal-title":"Am J Psychiatry"},{"issue":"3","key":"zoi200224r40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s002130050620","article-title":"The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects.","volume":"137","author":"van Berckel","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"zoi200224r41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/0269881108098612","article-title":"Ethanol-like effects of thiopental and ketamine in healthy humans.","volume":"24","author":"Dickerson","year":"2010","journal-title":"J Psychopharmacol"},{"issue":"2","key":"zoi200224r42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/hbm.10064","article-title":"Ketamine and fMRI BOLD signal: distinguishing between effects mediated by change in blood flow versus change in cognitive state.","volume":"18","author":"Abel","year":"2003","journal-title":"Hum Brain Mapp"},{"issue":"6","key":"zoi200224r43","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.biopsych.2016.06.019","article-title":"Role of N-methyl-D-aspartate receptors in action-based predictive coding deficits in schizophrenia.","volume":"81","author":"Kort","year":"2017","journal-title":"Biol Psychiatry"},{"issue":"3","key":"zoi200224r44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archpsyc.57.3.270","article-title":"Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.","volume":"57","author":"Anand","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"zoi200224r45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s002130051049","article-title":"Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.","volume":"145","author":"Krystal","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"zoi200224r46","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/sj.npp.1300252","article-title":"Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients.","volume":"28","author":"Krystal","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"zoi200224r47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00002826-200203000-00008","article-title":"Effects of subanesthetic doses of ketamine on sensorimotor information processing in healthy subjects.","volume":"25","author":"Micallef","year":"2002","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"zoi200224r48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0269881107077768","article-title":"Ketamine effects on CNS responses assessed with MEG\/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man.","volume":"21","author":"Boeijinga","year":"2007","journal-title":"J Psychopharmacol"},{"issue":"9","key":"zoi200224r49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyv040","article-title":"Ketamine-induced modulation of the thalamo-cortical network in healthy volunteers as a model for schizophrenia.","volume":"18","author":"H\u00f6flich","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"zoi200224r50","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1017\/S1461145712000764","article-title":"Vulnerability to psychotogenic effects of ketamine is associated with elevated D2\/3-receptor availability.","volume":"16","author":"Vernaleken","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"zoi200224r51","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2012.05.009","article-title":"Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.","volume":"72","author":"D\u2019Souza","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"4","key":"zoi200224r52","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00213-009-1758-2","article-title":"The interactive effects of ketamine and nicotine on human cerebral blood flow.","volume":"208","author":"Rowland","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"zoi200224r53","first-page":"33","article-title":"Ketamine-induced disruption of verbal self-monitoring linked to superior temporal activation.","volume":"44","author":"Stone","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"10","key":"zoi200224r54","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41386-018-0136-3","article-title":"The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects.","volume":"43","author":"Abdallah","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"zoi200224r55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0269881103017001698","article-title":"Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man.","volume":"17","author":"Passie","year":"2003","journal-title":"J Psychopharmacol"},{"issue":"9","key":"zoi200224r56","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1017\/S0033291709991619","article-title":"Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect.","volume":"40","author":"Horacek","year":"2010","journal-title":"Psychol Med"},{"issue":"1","key":"zoi200224r57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biopsych.2010.07.032","article-title":"Exploring the impact of ketamine on the experience of illusory body ownership.","volume":"69","author":"Morgan","year":"2011","journal-title":"Biol Psychiatry"},{"issue":"6","key":"zoi200224r58","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000438675","article-title":"Ketamine-induced hallucinations.","volume":"48","author":"Powers","year":"2015","journal-title":"Psychopathology"},{"issue":"2","key":"zoi200224r59","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neuroimage.2010.08.021","article-title":"Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency.","volume":"54","author":"Nagels","year":"2011","journal-title":"Neuroimage"},{"issue":"11","key":"zoi200224r60","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/mp.2012.194","article-title":"Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans.","volume":"18","author":"Driesen","year":"2013","journal-title":"Mol Psychiatry"},{"key":"zoi200224r61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fpsyt.2014.00003","article-title":"Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans.","volume":"5","author":"Mathalon","year":"2014","journal-title":"Front Psychiatry"},{"issue":"4","key":"zoi200224r62","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00213-018-4828-5","article-title":"Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study.","volume":"235","author":"Morrison","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"21","key":"zoi200224r63","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s00213-017-4706-6","article-title":"The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.","volume":"234","author":"van de Loo","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"zoi200224r64","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00001756-199504190-00011","article-title":"Ketamine activates psychosis and alters limbic blood flow in schizophrenia.","volume":"6","author":"Lahti","year":"1995","journal-title":"Neuroreport"},{"issue":"1","key":"zoi200224r65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"zoi200224r66","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/sj.npp.1300824","article-title":"Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia.","volume":"30","author":"Holcomb","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"zoi200224r67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/hipo.1070","article-title":"Probing the human hippocampus using rCBF: contrasts in schizophrenia.","volume":"11","author":"Medoff","year":"2001","journal-title":"Hippocampus"},{"issue":"5","key":"zoi200224r68","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0022-3956(96)00018-0","article-title":"Absence of ketamine effects on memory and other cognitive functions in schizophrenia patients.","volume":"30","author":"LaPorte","year":"1996","journal-title":"J Psychiatr Res"},{"issue":"10","key":"zoi200224r69","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0006-3223(00)01037-4","article-title":"Long-term outcome of patients who receive ketamine during research.","volume":"49","author":"Lahti","year":"2001","journal-title":"Biol Psychiatry"},{"issue":"8","key":"zoi200224r70","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0006-3223(96)00546-X","article-title":"Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.","volume":"42","author":"Malhotra","year":"1997","journal-title":"Biol Psychiatry"},{"issue":"2-3","key":"zoi200224r71","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophr Res"},{"issue":"12","key":"zoi200224r72","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0006-3223(95)00046-1","article-title":"Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?","volume":"38","author":"Farber","year":"1995","journal-title":"Biol Psychiatry"},{"issue":"4","key":"zoi200224r73","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00213-006-0409-0","article-title":"Greater vulnerability to the amnestic effects of ketamine in males.","volume":"187","author":"Morgan","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"1-2","key":"zoi200224r74","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0006-8993(01)02079-0","article-title":"A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide.","volume":"895","author":"Jevtovic-Todorovic","year":"2001","journal-title":"Brain Res"},{"issue":"10","key":"zoi200224r75","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0028-3908(86)90156-5","article-title":"Seasonal and sex influences on ketamine-induced analgesia and catalepsy in the rat: a possible role for melatonin.","volume":"25","author":"Winters","year":"1986","journal-title":"Neuropharmacology"},{"issue":"1","key":"zoi200224r76","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"issue":"2","key":"zoi200224r77","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00213-007-0706-2","article-title":"Psychiatric safety of ketamine in psychopharmacology research.","volume":"192","author":"Perry","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"zoi200224r78","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"18","key":"zoi200224r79","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-014-3664-5","article-title":"Ketamine administration in depressive disorders: a systematic review and meta-analysis.","volume":"231","author":"Fond","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"zoi200224r80","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.neuroimage.2011.06.045","article-title":"Ketamine effects on brain function\u2014simultaneous fMRI\/EEG during a visual oddball task.","volume":"58","author":"Musso","year":"2011","journal-title":"Neuroimage"},{"issue":"12","key":"zoi200224r81","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.57.12.1139","article-title":"Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.","volume":"57","author":"Umbricht","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"zoi200224r82","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00213-004-2066-5","article-title":"Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine.","volume":"179","author":"Cho","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"zoi200224r83","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jrsm.1166","article-title":"Random-effects models for meta-analytic structural equation modeling: review, issues, and illustrations.","volume":"7","author":"Cheung","year":"2016","journal-title":"Res Synth Methods"},{"key":"zoi200224r14","volume-title":"Scale for the Assessment of Positive Symptoms","author":"Andreasen","year":"1984"},{"key":"zoi200224r15","volume-title":"Scale for the Assessment of Negative Symptoms","author":"Andreasen","year":"1984"},{"key":"zoi200224r17","unstructured":"Higgins JP, Green S, eds. Cochrane handbook for systematic reviews of interventions. Figure 8.6.a. John Wiley & Sons; 2011. Accessed August 24, 2019. https:\/\/handbook-5-1.cochrane.org\/chapter_8\/figure_8_6_a_example_of_a_risk_of_bias_table_for_a_single.htm"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2766225\/beck_2020_oi_200224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T15:03:36Z","timestamp":1590073416000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2766225"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.4693","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,21]]}}}